Bareli (Uttar Pradesh):Saba Parveen, mother of a six-month-old Manha, who is suffering from an autoimmune disease, Spinal Muscular Atrophy Type-1 disease (SMA) has appealed to the Chief Minister of Uttar Pradesh and Prime Minister Narendra Modi for financial support as to afford the treatment for the disease, Zolgesma which costs 22 crores. Zolgensma is a single-dose intravenous injection gene therapy in which the defective SMN1 gene is replaced through an adenoviral vector, and is currently not available in India and is imported from the US.
As the doctors diagnosed Manha with SMA, even her father left them to feed for themselves.
Spinal Muscular Atrophy is a progressive neuromuscular disease caused due to a defect in the SMN1 gene. The affected children develop muscle weakness involving upper and lower limbs initially, but over time develop difficulties in breathing and swallowing. SMA affects one in 10,000 children on an average. There are nearly 800 children suffering from SMA in India.